All In Biotech

Drug Trial Radar · NCT05889156

Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia

A Multicenter, Randomized, Double-Blind, Placebo-Controlled 28- Day Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of NST-1024 400 mg BID Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects

Last checked: Nov 19, 2026Latest source record: Apr 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Jun 30, 2023

Primary completion

Mar 18, 2025

Study completion Apr 11, 2025

Sponsor

Lead sponsor
NorthSea Therapeutics B.V.Industry
Sponsor type
Industry
First posted
Jun 5, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase IIa,multicentre proof of concept study consisting of 2 study periods to study Treatment with NST-1024 as an adjunct to diet to reduce triglyceride (TG) levels in subjects with TG levels of ≥500 mg/dL and ≤2000 mg/dL; determined by percentage change in TG from baseline after 28 days of treatment. The two periods consist of: 1. A 3-week screening period that includes a TG qualifying period, and 2. A 28-days, double-blind, randomized, parallel group, placebo-controlled treatment period. Subjects will return to the study site for a follow-up visit 2 weeks after the last dose. Approximately 50 subjects will be randomized at approximately 15-35 centers in USA.

Conditions

  • High Triglycerides

Interventions

  • NST-1024Drug

    400 mg BID

  • PlaceboOther

    matched placebo to active arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the efficacy of NST-1024 by percentage change in TGTime frame: 4 weeks

Locations

31 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama - Heersink School of Medicine

    Birmingham, Alabama

  • Alliance for Multispecialty Research, LLC (AMR) - Daphne

    Daphne, Alabama

  • Alliance for Multispecialty Research, LLC (AMR) - Phoenix

    Tempe, Arizona

  • Velocity Clinical Research, San Diego

    La Mesa, California

  • Velocity Clinical Research, North Hollywood

    North Hollywood, California

  • Velocity Clinical Research - Costal Heart

    Santa Ana, California

  • Lynn Institute of Denver

    Aurora, Colorado

  • Velocity Clinical Research, New Smyrna Beach

    Edgewater, Florida

  • Clearwater Cardiovascular Consultants

    Largo, Florida

  • Floridian Clinical Research

    Miami Lakes, Florida

  • Metabolic Research Institute, Inc.

    West Palm Beach, Florida

  • Lifeline Primary Care/ CCT Research

    Lilburn, Georgia

  • Velocity Clinical Research - Boise

    Meridian, Idaho

  • Deaconess Clinic - Indiana

    Evansville, Indiana

  • Velocity Clinical Research, Valparaiso

    Valparaiso, Indiana

  • Alliance for Multispecialty Research, LLC (AMR) - Newton

    Newton, Kansas

  • University of Louisville - UoL Physicians Outpatient Center

    Louisville, Kentucky

  • Troy Internal Medicine

    Troy, Michigan

  • Clay Platte Family Medicine / CCT Research

    Kansas City, Missouri

  • Velocity Clinical Research - Kearney

    Lincoln, Nebraska

  • Cenexel HRI

    Berlin, New Jersey

  • Velocity Clinical Research - Cincinnati

    Cincinnati, Ohio

  • Velocity Clinical Research - Cleveland

    Cleveland, Ohio

  • Hatboro Medical Associates/ CCT Research

    Hatboro, Pennsylvania

  • Mercado Medical Practice / CCT Research

    Philadelphia, Pennsylvania

  • Palmetto Clinical Reserach

    Summerville, South Carolina

  • Velocity Clinical Research - Union

    Union, South Carolina

  • Apex Mobile Clinical Research

    Bellaire, Texas

  • Pinnacle Clinical Research - San Antonio

    San Antonio, Texas

  • Ogden Clinic, Mount View/CCT Research

    Pleasant View, Utah

  • Velocity Clinical Research - Salt Lake City

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.